Neuren Pharmaceuticals | NEU - Selling And Administration Expenses


Neuren Pharmaceuticals reported AUD3.74M in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alaunos Therapeutics USD 447K 138K Mar/2026
Avita Medical AUD 19.03M 1.95M Dec/2025
Clinuvel Pharmaceuticals AUD 3.85M 5.27M Dec/2025
Dianthus Therapeutics USD 12.47M 5.89M Mar/2026
Genetic Signatures AUD 908K 31K Dec/2025
Ionis Pharmaceuticals USD 130.07M 20.92M Jun/2026
Medical Developments International AUD 2.84M 4.19M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Organon & Co USD 434M 10M Jun/2026
Paradigm Biopharmaceuticals AUD 2.83M 1.22M Dec/2025
PYC Therapeutics AUD 328.4K 1.8M Dec/2025
Starpharma Holdings AUD 4.42M 2.86M Dec/2025
Tectonic Therapeutic USD 6.43M 2.99M Mar/2026
Telix Pharmaceuticals AUD 107.02M 13.54M Jun/2026
Viatris USD 1.13B 205.7M Jun/2026
Xeris Pharmaceuticals USD 53.14M 10.51M Mar/2026